Bristol-Myers Squibb Company (ETR: BRM)
Germany
· Delayed Price · Currency is EUR
50.78
-1.71 (-3.26%)
Nov 7, 2024, 5:35 PM CET
BRM Revenue
Bristol-Myers Squibb Company had revenue of $11.89B USD in the quarter ending September 30, 2024, with 8.44% growth. This brings the company's revenue in the last twelve months to $47.44B, up 5.56% year-over-year. In the year 2023, Bristol-Myers Squibb Company had annual revenue of $45.01B, down -2.50%.
Revenue (ttm)
$47.44B
Revenue Growth
+5.56%
P/S Ratio
n/a
Revenue / Employee
$1.39M
Employees
34,100
Market Cap
102.87B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
Dec 31, 2019 | 26.15B | 3.58B | 15.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBristol-Myers Squibb Company News
- 3 days ago - Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo - Benzinga
- 3 days ago - How Is The Market Feeling About Bristol-Myers Squibb? - Benzinga
- 5 days ago - Bristol-Myers Squibb's Cobenfy Shows Sustained Efficacy in Schizophrenia Treatment - GuruFocus
- 6 days ago - Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade - Investor's Business Daily
- 6 days ago - Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious - Benzinga
- 7 days ago - Bristol Myers Squibb Presents New Long-term Data from the EMERGENT Program Evaluating COBENFY (xanomeline and trospium chloride) in Adults with Schizophrenia at Psych Congress 2024 - Wallstreet:Online
- 7 days ago - Bristol-Myers Squibb Company (BMY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript - The Motley Fool